Objective Cardiovascular diseases are a leading cause of morbidity and mortality in SLE. In this target population, ...

A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% of all patients and ...

A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% of all patients and ...

Expert perspectives on how multidisciplinary teams, innovation, and long-term care are redefining aortic care.

The aortic surgery fellowship will provide the trainee with knowledge and technical skills in the preoperative evaluation, operative management, and postoperative care of patients with aortic ...

Atherosclerosis (AS) is a leading cause of mortality worldwide. AS is a progressive disease and so, early detection and ...

Please provide your email address to receive an email when new articles are posted on . In patients with diabetes and high LDL but no heart disease, evolocumab reduced major adverse CV events compared ...

Please provide your email address to receive an email when new articles are posted on . Parunoflast significantly and durably reduced C-reactive protein levels over 12 weeks in people with obesity.

Low levels of high-density lipoprotein (HDL) cholesterol correlate with an increased risk of atherosclerosis. Thus, pharmacological agents that increase HDL should be associated with reductions in ...

Atherosclerosis is a lifelong, inflammatory arterial disease that starts in childhood. The condition eventually involves all three layers of the arterial wall but is thought to begin in the intima.